Refine Results
- view as grid
- view as list
Disparities in Reaching COVID-19 Vaccination Benchmarks: Projected Vaccination Rates by Race/Ethnicity as of July 4
To explore potential disparities in meeting COVID-19 vaccination benchmarks, this analysis uses state-reported vaccination data by race/ethnicity to project vaccine coverage going forward, by state and nationally.
Issue Brief Read More
State COVID-19 Data and Policy Actions
Explore state-level data on a variety of COVID-19 metrics, including the latest hotspots, cases and deaths by race and ethnicity and at long-term care facilities. Find up-to-date information on state policy actions on social distancing measures and reducing barriers to COVID-19 testing and treatment.
Issue Brief Read More
KFF COVID-19 Vaccine Monitor: Profile Of The Unvaccinated
This report explores the roughly a third of adults who have not received a COVID-19 vaccine and finds that, compared to vaccinated adults, they are younger, more likely to identify as Republican or Republican-leaning, with lower incomes and education levels, and more likely to be uninsured.
Poll Finding Read More
Who Remains Unvaccinated? A COVID-19 Vaccine Monitor Analysis
As more people across the country get at least an initial dose of a COVID-19 vaccine, public health officials are increasingly trying to reach the shrinking pool of unvaccinated adults – now roughly a third of all adults. The latest KFF COVID-19 Vaccine Monitor report explores this group’s demographic profile…
News Release Read More
How Might Lowering the Medicare Age Affect Medicaid Enrollees?
This issue brief highlights key differences between Medicare and Medicaid and raises questions about how a policy to lower the age of Medicare eligibility could affect individuals who are currently enrolled in Medicaid.
Issue Brief Read More
FDA’s Approval of Biogen’s New Alzheimer’s Drug Has Huge Cost Implications for Medicare and Beneficiaries
The question of what would happen when a new, expensive prescription drug comes to market for a disease like Alzheimer’s that afflicts millions of people has loomed large in discussions over drug prices in the U.S. This brief analyzes the cost implications for Medicare and beneficiaries associated with Biogen’s new FDA-approved Alzheimer’s drug, which will cost $56,000 per year.
Issue Brief Read More
Implications of COVID-19 for Social Determinants of Health
This brief provides an overview of social determinants of health and a look at how adults are faring across an array of measures over a year into the pandemic.
Issue Brief Read More
Utilization and Spending Trends in Medicaid Outpatient Prescription Drugs, 2015-2019
Prescription drug spending in Medicaid and other health programs has returned to the national policy debate. This analysis examines Medicaid outpatient prescription drug utilization and spending before rebates over the 2015 to 2019 period, which is helpful for understanding recent cost drivers and areas for targeted policy action.
Issue Brief Read More
Medicaid Waiver Tracker: Approved and Pending Section 1115 Waivers by State
This Medicaid waiver tracker page aggregates tracking information on pending and approved Section 1115 Medicaid waivers. It includes resources such as an overview map and figure, detailed waiver topic tables, and explanatory briefs.
Issue Brief Read More
Recent and Anticipated Actions to Reverse Trump Administration Section 1557 Non-Discrimination Rules
The Biden Administration has started taking steps to reverse Trump Administration policy and regulations that significantly narrowed the implementation and administrative enforcement of Section 1557, the Affordable Care Act’s nondiscrimination provision, particularly as the regulations apply to gender identity and sexual orientation. In addition, several lawsuits challenging the regulations, which…
Issue Brief Read More